This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Traumatic subarachnoid haemorrhage
ST19_TRAUMAT_SUBAR_HAEMORRHAGE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1368 |
4. Check minimum number of eventsNone |
1368 |
5. Include endpointsNone |
1368 |
6. Filter based on genotype QC (FinnGen only) |
1368 |
Control definitions (FinnGen only)
- Control exclude
- NEURODIS
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ST19_SAHTRAU
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S06
- Name in latin
- Haemorrhagia subarachnoidalis traumatica
Similar endpoints
↥List of similar endpoints to
Traumatic subarachnoid haemorrhage
based on the number of shared cases.
Similar with more cases:
- severe traumatic brain injury, does not include concussion
- Intracranial trauma
- Bleeding
- Neurological diseases, wide definition
- Injury, poisoning and certain other consequences of external causes
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1368 | 515 | 853 |
| Unadjusted period prevalence (%) | 0.30 | 0.18 | 0.38 |
| Median age at first event (years) | 67.53 | 69.36 | 66.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1207
- Matched controls
- 12070
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S06.0
ICD-10 Finland
Concussion
87.0
323.0
366
60
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
13.1
323.0
820
1674
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
323.0
542
*
AA1AD
NOMESCO Finland
CT of head and brain
27.8
323.0
775
731
S06.3
ICD-10 Finland
Focal brain injury
+∞
323.0
336
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
323.0
1189
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
45.1
221.6
274
78
T90.5
ICD-10 Finland
Sequelae of intracranial injury
742.7
197.0
189
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
178.7
167
*
W19
ICD-10 Finland
Unspecified fall
11.7
167.2
336
386
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
1695.4
154.6
147
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
769.2
141.9
137
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
7.3
138.5
379
708
S02.11
ICD-10 Finland
Fracture of base of skull, open
675.1
125.7
122
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
118.7
112
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.7
112.4
376
882
X59
ICD-10 Finland
Exposure to unspecified factor
5.5
112.4
391
961
N03AX14
ATC
levetiracetam; systemic
115.4
107.1
115
11
XA800
NOMESCO Finland
Neuropsychological investigation
48.4
106.9
130
30
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
151.0
105.0
110
8
W10
ICD-10 Finland
Fall on and from stairs and steps
13.3
99.3
181
158
S01.0
ICD-10 Finland
Open wound of scalp
8.5
99.2
233
329
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.2
95.5
347
873
G47.3
ICD-10 Finland
Sleep apnoea
16.6
93.5
154
105
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
89.7
85
*
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
317.9
87.9
88
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
83.3
79
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.0
78.9
191
277
G40.9
ICD-10 Finland
Epilepsy, unspecified
785.5
76.1
74
*
K90
ICPC
Stroke/cerebrovascular accident
157.4
70.8
74
5
W00
ICD-10 Finland
Fall on same level involving ice and snow
5.5
68.2
221
471
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
45.5
66.0
81
19
S06.9
ICD-10 Finland
Intracranial injury, unspecified
+∞
65.2
62
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
11.3
61.2
119
116
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
57.9
60.5
71
13
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
59.9
57
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.2
59.5
130
157
R4120
NOMESCO Finland
Occupational therapy
8.8
58.7
131
164
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.3
58.1
126
150
N80
ICPC
Head injury other
20.7
56.6
85
44
A28
ICPC
Limited function/disability NOS
3.9
56.3
268
828
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
55.6
53
*
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
43.6
53.4
66
16
N02BE01
ATC
paracetamol; systemic, rectal
3.2
53.4
1037
7883
S02.10
ICD-10 Finland
Fracture of base of skull, closed
101.4
53.3
58
6
N05AH04
ATC
quetiapine; oral
4.1
50.4
216
603
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
+∞
50.4
48
*
N03AF02
ATC
oxcarbazepine; oral
42.0
48.3
60
15
N06AX11
ATC
mirtazapine; oral
2.8
47.5
396
1805
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
46.1
44
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
11.1
43.8
85
82
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
43.0
41
*
X58
ICD-10 Finland
Exposure to other specified factors
3.6
42.4
213
675
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
14.0
42.2
73
55
R53
ICD-10 Finland
Malaise and fatigue
3.2
42.1
258
949
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
17.2
42.0
67
41
S06.4
ICD-10 Finland
Epidural haemorrhage
+∞
41.9
40
*
W17
ICD-10 Finland
Other fall from one level to another
6.8
41.6
109
173
S22.4
ICD-10 Finland
Multiple fractures of ribs
11.8
40.6
76
68
L28
ICPC
Limited function/disability (L)
3.2
39.5
233
832
R55
ICD-10 Finland
Syncope and collapse
3.8
39.3
181
532
N03AG01
ATC
valproic acid; systemic, rectal
9.0
39.1
85
101
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
38.7
37
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
+∞
38.7
37
*
P20
ICPC
Memory disturbance
3.7
38.7
183
549
N06AB10
ATC
escitalopram; oral
3.2
36.1
218
786
S06.8
ICD-10 Finland
Other intracranial injuries
+∞
35.6
34
*
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
20.5
35.5
53
27
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
26.2
34.7
48
19
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
34.5
33
*
R4110
NOMESCO Finland
Physiotherapy
2.4
34.5
357
1777
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
34.4
330
1580
R42
ICD-10 Finland
Dizziness and giddiness
2.8
34.1
260
1091
K91
ICPC
Cerebrovascular disease
78.5
34.0
38
5
R51.80
ICD-10 Finland
Headache
4.0
33.8
146
403
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.1
33.7
142
384
N05AX08
ATC
risperidone; systemic
5.2
32.6
106
220
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
7.8
32.3
76
103
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
325.1
32.0
32
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
48.9
31.7
38
8
S00.0
ICD-10 Finland
Superficial injury of scalp
11.6
31.5
59
53
R5140
NOMESCO Finland
Monitoring the use of the aid
6.9
31.4
80
122
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
31.4
30
*
N03AF01
ATC
carbamazepine; oral, rectal
7.4
31.3
76
108
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
31.2
526
3253
S22.3
ICD-10 Finland
Fracture of rib
4.5
31.1
115
274
PA2AD
NOMESCO Finland
CT angiography of brain
320.7
31.0
31
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
10.1
30.9
62
64
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
30.3
29
*
G72.8
ICD-10 Finland
Other specified myopathies
309.7
29.9
30
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.4
29.5
111
269
ACC51
NOMESCO Finland
Release of median nerve
38.1
29.4
37
10
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
18.6
29.3
45
25
P15
ICPC
Chronic alcohol abuse
8.5
29.3
65
80
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
29.0
234
1004
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
28.2
27
*
N06AB04
ATC
citalopram; systemic
2.6
28.0
231
1004
N07BB01
ATC
disulfiram; oral
5.7
27.9
82
151
WX002
NOMESCO Finland
Sedation and analgesia
2.4
27.9
269
1270
F10.09
ICD-10 Finland
Alcohol intoxication UNS
10.2
27.6
55
56
F10.20
ICD-10 Finland
Alcohol dependence currently independent
11.0
27.2
52
49
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
27.2
180
684
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.2
27.0
87
179
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
7.2
26.5
65
94
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
6.6
26.4
69
109
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
9.5
26.2
54
59
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
26.1
25
*
J01DB01
ATC
cefalexin; oral
2.0
26.0
910
7245
N02AX02
ATC
tramadol; systemic, rectal
2.0
25.6
471
2947
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
29.1
25.5
34
12
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.9
25.4
110
303
S02.70
ICD-10 Finland
Multiple fractures involving skull and facial bones, closed
51.2
25.3
30
6
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.5
25.3
67
108
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
25.1
24
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.8
24.8
111
315
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
14.0
24.6
42
31
QAB00
NOMESCO Finland
Suture of skin of head or neck
11.3
24.5
46
42
N06DX01
ATC
memantine; oral
6.1
24.5
68
117
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
22.5
24.4
35
16
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
19.5
24.0
36
19
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
23.8
196
845
N06AX16
ATC
venlafaxine; oral
3.2
23.7
132
442
N05CF01
ATC
zopiclone; oral
2.0
23.6
386
2291
N05BA04
ATC
oxazepam; oral
2.3
23.5
263
1327
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
6.8
23.2
59
90
N06DA02
ATC
donepezil; oral
6.1
23.1
64
110
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
8.1
22.9
52
67
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.3
22.9
122
398
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
7.0
22.8
57
85
AAF00
NOMESCO Finland
Ventriculostomy
234.1
22.7
23
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
122.3
22.6
24
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
7.8
22.5
52
69
WX892
NOMESCO Finland
Monitored bed care
3.3
22.4
117
376
C07AB07
ATC
bisoprolol; oral
1.8
22.3
567
3924
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
11.7
22.3
41
36
G20
ICD-10 Finland
Parkinson disease
35.8
22.1
28
8
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
21.9
102
299
S18
ICPC
Laceration/cut
1.9
21.9
476
3117
WX780
NOMESCO Finland
Remote monitoring CPAP
223.8
21.7
22
*
SPAT1229
SPAT
Assessment of need for aid
3.5
21.6
105
319
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
21.5
123
421
N19
ICPC
Speech disorder
31.8
21.5
28
9
N03AX16
ATC
pregabalin; oral
2.3
21.5
223
1081
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
21.3
143
543
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
21.2
314
1777
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.7
21.2
95
270
AA3AD
NOMESCO Finland
CT of face
28.6
21.0
28
10
N18
ICPC
Paralysis/weakness
19.8
20.9
31
16
R4150
NOMESCO Finland
Neuropsychological rehabilitation
78.2
20.7
23
*
WX723
NOMESCO Finland
CPAP therapy
213.4
20.6
21
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
20.6
92
261
SPAT1216
SPAT
Assessment of functional ability
2.4
20.5
184
827
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
20.5
249
1292
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
20.3
474
3156
A02BC02
ATC
pantoprazole; systemic
1.8
20.3
691
5198
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
19.8
19
*
N05BA01
ATC
diazepam; systemic, rectal
2.6
19.8
157
657
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
19.8
294
1661
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
19.8
164
707
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.5
19.7
95
287
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
203.1
19.6
20
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
19.6
107
355
Y94.8
ICD-10 Finland
Other leisure activity accident
6.3
19.6
52
85
R41.0
ICD-10 Finland
Disorientation, unspecified
7.3
19.5
47
67
NB6AA
NOMESCO Finland
Humerus X-ray examination
9.0
19.5
41
47
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
19.4
111
380
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.4
19.4
46
64
R4130
NOMESCO Finland
Speech therapy
12.0
19.3
35
30
F10.24
ICD-10 Finland
Alcohol depence active use
11.2
19.3
36
33
S09.9
ICD-10 Finland
Unspecified injury of head
14.3
19.1
32
23
S42.2
ICD-10 Finland
Fracture of upper end of humerus
4.1
19.0
76
195
P16
ICPC
Acute alcohol abuse
9.1
18.7
39
44
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
18.7
142
582
X57
ICD-10 Finland
Unspecified privation
6.4
18.6
49
79
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.3
18.6
41
51
WX872
NOMESCO Finland
Intensive care
3.5
18.5
90
273
N05AA02
ATC
levomepromazine; systemic
5.0
18.4
60
126
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
30.5
18.4
24
8
N06AX21
ATC
duloxetine; oral
3.3
18.3
95
303
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
44.7
18.3
22
5
M79.6
ICD-10 Finland
Pain in limb
1.9
18.2
344
2116
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
12.6
18.2
32
26
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
8.5
18.0
39
47
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
17.8
656
4963
AA1XD
NOMESCO Finland
Other special CT of head and brain
67.6
17.8
20
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
+∞
17.7
17
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
17.7
17
*
S02.01
ICD-10 Finland
Fracture of the upper part of the head open
+∞
17.7
17
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
+∞
17.7
17
*
S70.0
ICD-10 Finland
Contusion of hip
5.3
17.7
54
105
G51.0
ICD-10 Finland
Bell palsy
37.3
17.6
22
6
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
4.5
17.5
62
142
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
17.2
17.4
27
16
A04
ICPC
Weakness/tiredness general
2.5
17.3
143
613
S27.3
ICD-10 Finland
Other injuries of lung
42.6
17.3
21
5
ZXA05
NOMESCO Finland
Left side
1.9
17.3
306
1834
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.1
17.2
47
80
N06DA03
ATC
rivastigmine; oral, transdermal
7.9
17.2
39
51
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
32.0
17.1
22
7
PA7BD
NOMESCO Finland
CT angiography of neck and brain
16.2
17.1
27
17
Z02.7
ICD-10 Finland
Issue of medical certificate
3.6
17.0
78
226
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
17.0
178
858
Y94.0
ICD-10 Finland
Accident at home
7.7
17.0
39
52
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
9.7
17.0
34
36
WX730
NOMESCO Finland
Conventional respirator
9.7
17.0
34
36
B01AC04
ATC
clopidogrel; oral
2.2
16.9
180
876
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
16.7
221
1180
N29
ICPC
Neurological sympt/complt other
12.9
16.7
29
23
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.2
16.6
63
155
C03CA01
ATC
furosemide; systemic
1.8
16.5
360
2310
SPAT1254
SPAT
Administration of medicine
2.3
16.4
169
808
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
16.4
59
138
C09AA05
ATC
ramipril; oral
1.9
16.3
301
1824
WX882
NOMESCO Finland
High dependency care
5.4
16.1
48
91
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
8.0
16.1
36
46
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
11.8
16.1
29
25
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
16.1
213
1140
N17
ICPC
Vertigo/dizziness
2.5
16.1
127
532
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
16.0
106
399
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
15.9
166
799
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
15.7
81
258
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
13.1
15.7
27
21
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.5
15.7
73
215
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
15.7
15
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
15.7
15
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
15.7
15
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
15.7
15
*
P03
ICPC
Feeling depressed
3.4
15.6
76
232
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
86.2
15.6
17
*
F05.9
ICD-10 Finland
Delirium, unspecified
8.7
15.5
33
39
T74.1
ICD-10 Finland
Physical abuse
9.6
15.5
31
33
N28
ICPC
Limited function/disability (N)
15.0
15.4
25
17
L17
ICPC
Foot/toe symptom/complaint
1.9
15.3
255
1485
S42.0
ICD-10 Finland
Fracture of clavicle
4.4
15.3
56
133
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
15.3
76
236
Z72.1
ICD-10 Finland
Alcohol use
9.9
15.2
30
31
V03.1
ICD-10 Finland
Pedestrian injured in collision with car, pick-up truck or van, traffic accident
29.0
15.2
20
7
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.8
15.2
297
1830
ZXA00
NOMESCO Finland
Right side
1.8
15.1
307
1914
R1260
NOMESCO Finland
Evaluation of communicative skills
12.0
15.1
27
23
Y96.9
ICD-10 Finland
Unspecified type of accident
8.2
15.1
33
41
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
15.0
92
331
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
8.8
14.8
31
36
NC2AA
NOMESCO Finland
Forearm X-ray examination
9.9
14.7
29
30
S27.0
ICD-10 Finland
Traumatic pneumothorax
9.9
14.7
29
30
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.9
14.7
48
102
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.7
14.6
50
111
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
14.6
14
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
14.6
14
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
14.6
14
*
WX110
NOMESCO Finland
Local anesthesy
1.6
14.5
695
5508
G44.2
ICD-10 Finland
Tension-type headache
3.2
14.4
77
252
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
15.6
14.4
23
15
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
8.3
14.3
31
38
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.5
14.3
42
79
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
13.6
14.2
24
18
V19
ICD-10 Finland
Pedal cyclist injured in other and unspecified transport accidents
5.1
14.2
44
88
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
14.2
170
869
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.1
14.2
80
271
W11
ICD-10 Finland
Fall on and from ladder
5.7
14.1
40
72
N02AA05
ATC
oxycodone; systemic
2.1
14.1
175
908
S02.80
ICD-10 Finland
Fractures of other skull and facial bones, closed
54.0
13.8
16
*
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
20.3
13.8
20
10
JN4BD
NOMESCO Finland
Extensive body CT
2.2
13.7
145
703
N06AB03
ATC
fluoxetine; oral
2.5
13.7
114
489
N87
ICPC
Parkinsonism
76.0
13.6
15
*
B01AA03
ATC
warfarin; systemic
1.8
13.6
254
1536
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
13.6
13
*
AAK80
NOMESCO Finland
Partial excision of skull cap
+∞
13.6
13
*
N06AA09
ATC
amitriptyline; systemic
2.7
13.5
92
354
V18.4
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident, driver injured in traffic accident
7.5
13.5
31
42
C10AA01
ATC
simvastatin; oral
1.6
13.5
497
3660
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
13.4
131
608
I95.1
ICD-10 Finland
Orthostatic hypotension
4.3
13.4
49
117
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.4
13.3
64
194
Y07
ICD-10 Finland
Other maltreatment
14.0
13.3
22
16
S72.0
ICD-10 Finland
Fracture of neck of femur
3.8
13.2
56
153
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
40.5
13.2
16
*
P29
ICPC
Psychological sympt/compl other
3.7
13.2
58
164
L76
ICPC
Fracture: other
4.5
13.1
46
106
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
11.1
13.0
24
22
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.0
315
2058
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.4
12.9
38
72
S01.8
ICD-10 Finland
Open wound of other parts of head
7.8
12.9
29
38
DFF00
NOMESCO Finland
Pure tone audiometry
2.4
12.9
115
512
A01
ICPC
Pain general/multiple sites
2.8
12.8
82
301
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
5.3
12.8
38
73
V14.9
ICD-10 Finland
Pedal cyclist injured in collision with heavy transport vehicle or bus, unspecified pedal cyclist injured in traffic accident
14.2
12.8
21
15
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.8
12.8
83
310
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.9
12.7
31
46
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
70.6
12.6
14
*
AA5PD
NOMESCO Finland
CT examination of brain pefusion
70.6
12.6
14
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
12.6
78
283
Z71.8
ICD-10 Finland
Other specified counselling
1.8
12.6
225
1338
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
12.5
12
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
12.5
12
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
24.6
12.5
17
7
AA1DD
NOMESCO Finland
Head and neck CT
131.2
12.5
13
*
GBB00
NOMESCO Finland
Tracheostomy
7.0
12.4
30
44
L08
ICPC
Shoulder symptom/complaint
1.9
12.4
182
1008
J01MA02
ATC
ciprofloxacin; systemic
1.6
12.4
409
2908
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
12.3
133
647
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
12.3
70
239
SPAT1234
SPAT
Support of social functional capacity
3.2
12.2
65
213
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.5
12.2
28
38
SPAT1310
SPAT
Counselling related to known health issue
1.7
12.2
309
2043
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
12.2
58
175
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
4.2
12.2
45
109
N05CD07
ATC
temazepam; oral
2.1
12.2
141
710
N03AB02
ATC
phenytoin; systemic
16.0
12.2
19
12
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
18.2
12.1
18
10
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
21.5
12.0
17
8
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
11.9
119
560
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
47.1
11.9
14
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
47.1
11.9
14
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
11.8
100
433
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
14.8
11.8
19
13
N03AE01
ATC
clonazepam; systemic
3.6
11.8
52
148
TAB00
NOMESCO Finland
Lumbar puncture
6.4
11.7
30
48
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.3
11.7
35
68
A06AD11
ATC
lactulose; oral
2.0
11.6
159
855
S02.47
ICD-10 Finland
Multiple fracture of the upper jaw bone
65.6
11.6
13
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
11.6
176
986
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
11.6
155
826
G30.8
ICD-10 Finland
Other Alzheimer disease
11.2
11.6
21
19
Z29
ICPC
Social problem NOS
6.2
11.5
30
49
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
11.5
341
2350
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
+∞
11.5
11
*
AAD12
NOMESCO Finland
Drainage of subdural fluid
+∞
11.5
11
*
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
+∞
11.5
11
*
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.9
11.4
68
241
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
11.3
285
1874
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
7.4
11.3
26
36
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
6.3
11.2
29
47
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
11.2
81
322
JN4AE
NOMESCO Finland
Focused Assessment with Sonography for Trauma (FAST) of torso
17.2
11.2
17
10
R35
ICD-10 Finland
Polyuria
2.7
11.2
74
280
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.1
11.2
43
109
P01
ICPC
Feeling anxious/nervous/tense
2.8
11.1
73
274
N03AX12
ATC
gabapentin; oral
2.2
11.1
116
558
P76
ICPC
Depressive disorder
3.4
11.1
52
156
M54.5
ICD-10 Finland
Low back pain
1.7
11.1
283
1870
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
11.1
129
651
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.0
318
2174
SPAT1301
SPAT
No procedures
1.6
10.9
316
2157
SPAT1053
SPAT
Memory test
1.9
10.9
170
958
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
7.9
10.9
24
31
N30.0
ICD-10 Finland
Acute cystitis
2.1
10.8
129
654
S80.0
ICD-10 Finland
Contusion of knee
2.9
10.8
64
227
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
10.8
384
2760
B01AB05
ATC
enoxaparin; parenteral
1.6
10.8
315
2157
R41.3
ICD-10 Finland
Other amnesia
6.2
10.8
28
46
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
7.3
10.8
25
35
AA1ED
NOMESCO Finland
Trauma CT of head and neck
18.0
10.7
16
9
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
10.7
120
595
C08CA01
ATC
amlodipine; oral
1.6
10.7
379
2722
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
60.5
10.6
12
*
A46
ICD-10 Finland
Erysipelas
1.9
10.6
159
885
G56.2
ICD-10 Finland
Lesion of ulnar nerve
10.1
10.5
20
20
H53.2
ICD-10 Finland
Diplopia
4.5
10.5
36
82
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.4
10.5
49
147
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
10.4
254
1651
S02.71
ICD-10 Finland
Multiple fractures involving skull and facial bones, open
110.9
10.4
11
*
S02.90
ICD-10 Finland
Fracture of skull and facial bones, part unspecified, closed
110.9
10.4
11
*
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
10.4
10
*
N03AX18
ATC
lacosamide; systemic
+∞
10.4
10
*
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
+∞
10.4
10
*
N05BA09
ATC
clobazam; oral
+∞
10.4
10
*
R20.2
ICD-10 Finland
Paraesthesia of skin
3.4
10.4
50
153
N06AB06
ATC
sertraline; oral
2.4
10.4
88
380
N03AX09
ATC
lamotrigine; oral
4.6
10.4
35
78
R50.9
ICD-10 Finland
Fever, unspecified
2.0
10.4
136
719
R1250
NOMESCO Finland
Evaluation of functional capability
7.2
10.3
24
34
W18
ICD-10 Finland
Other fall on same level
19.0
10.3
15
8
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.9
10.3
60
211
L14
ICPC
Leg/thigh symptom/complaint
2.5
10.2
81
338
WYA20
NOMESCO Finland
Home visit
6.7
10.2
25
38
RF220
NOMESCO Finland
NA
7.5
10.2
23
31
SPAT1263
SPAT
Sampling
1.5
10.1
407
3002
NB3AA
NOMESCO Finland
Clavicle X-ray examination
7.3
10.0
23
32
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
10.0
150
834
N05BA02
ATC
chlordiazepoxide; systemic
4.0
10.0
39
101
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.9
9.9
40
106
WX722
NOMESCO Finland
PEEP
4.4
9.9
35
82
S01.9
ICD-10 Finland
Open wound of head, part unspecified
4.9
9.9
31
64
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
16.9
9.9
15
9
G04BD12
ATC
mirabegron; oral
2.1
9.8
109
536
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
26.2
9.8
13
5
R13
ICD-10 Finland
Dysphagia
2.8
9.8
62
230
N01
ICPC
Headache
2.6
9.8
72
290
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.9
9.8
39
103
P06
ICPC
Sleep disturbance
2.5
9.7
75
309
M03BX01
ATC
baclofen; systemic
13.5
9.7
16
12
AAK00
NOMESCO Finland
Cranioplasty
55.4
9.7
11
*
N06AX03
ATC
mianserin; oral
3.3
9.6
47
146
S01.3
ICD-10 Finland
Open wound of ear
6.9
9.6
23
34
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.1
9.6
29
58
S42.1
ICD-10 Finland
Fracture of scapula
6.4
9.6
24
38
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
9.6
39
105
N05AH03
ATC
olanzapine; systemic
2.9
9.5
56
198
S00.8
ICD-10 Finland
Superficial injury of other parts of head
7.2
9.5
22
31
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
9.5
198
1226
J01FF01
ATC
clindamycin; systemic
1.6
9.5
256
1707
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.8
9.5
61
229
WX704
NOMESCO Finland
Intubation
2.6
9.5
70
282
S12.0
ICD-10 Finland
Fracture of first cervical vertebra
30.3
9.4
12
*
-1
NOMESCO Finland
NA
1.6
9.4
298
2072
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
9.4
9
*
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
9.4
9
*
H53.4
ICD-10 Finland
Visual field defects
6.5
9.3
23
36
AN1
HP
Coronary angiography
1.9
9.2
141
790
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.7
9.2
30
65
SPAT1240
SPAT
Therapeutic discussion
2.3
9.2
82
367
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
9.2
659
5460
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
9.1
218
1403
A29
ICPC
General symptom/complaint other
2.0
9.1
117
615
S01
ICD-10 Finland
Open wound of head
6.3
9.1
23
37
K02.1
ICD-10 Finland
Caries of dentine
1.5
9.1
515
4067
S52.5
ICD-10 Finland
Fracture of lower end of radius
2.2
9.1
97
470
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.4
9.1
19
23
SPAT1251
SPAT
Organisation of medication
3.3
9.0
44
137
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.1
9.0
18
20
A02BC05
ATC
esomeprazole; systemic
1.5
9.0
367
2700
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.4
9.0
77
339
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.0
467
3625
N05CF02
ATC
zolpidem; oral
1.8
8.9
159
941
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.2
8.8
32
78
R06.5
ICD-10 Finland
Mouth breathing
2.9
8.8
51
179
R02
ICPC
Shortness of breath/dyspnoea
2.0
8.8
112
586
S01.51
ICD-10 Finland
Open wound on lip
5.7
8.8
24
43
S20.2
ICD-10 Finland
Contusion of thorax
2.9
8.8
52
186
G50.0
ICD-10 Finland
Trigeminal neuralgia
14.1
8.7
14
10
I63.8
ICD-10 Finland
Other cerebral infarction
50.3
8.7
10
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
8.7
63
254
F03
ICD-10 Finland
Unspecified dementia
3.4
8.7
40
120
N05BA12
ATC
alprazolam; oral
2.1
8.6
94
461
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
5.5
8.6
24
44
R47.1
ICD-10 Finland
Dysarthria and anarthria
27.7
8.5
11
*
H02AB06
ATC
prednisolone; systemic
1.5
8.5
445
3446
G40
ICD-10 Finland
Epilepsy
90.6
8.4
9
*
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.3
8.4
40
123
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.7
8.4
54
203
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
8.4
205
1329
XCK00
NOMESCO Finland
Perimetry
2.3
8.4
73
324
U04
ICPC
Incontinence urine
2.9
8.4
48
167
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
8.3
8
*
AAD00
NOMESCO Finland
Evacuation of epidural haematoma
+∞
8.3
8
*
Y87.1
ICD-10 Finland
Sequelae of assault
+∞
8.3
8
*
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
+∞
8.3
8
*
S15.0
ICD-10 Finland
Injury of carotid artery
+∞
8.3
8
*
2161
FHL
Neck ligation, big brain
+∞
8.3
8
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
8.3
8
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
8.3
8
*
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
8.3
8
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
8.3
8
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
8.3
80
371
L03
ICPC
Low back symptom/complaint
1.7
8.3
198
1273
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
5.6
8.3
23
42
SPAT1252
SPAT
Overall medication plan or its review
2.3
8.3
75
338
L89
ICD-10 Finland
Decubitus ulcer and pressure area
5.9
8.3
22
38
AA1AA
NOMESCO Finland
Head X-ray examination
9.5
8.3
16
17
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.6
8.3
58
230
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.1
8.3
19
27
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
8.2
110
586
N06DA04
ATC
galantamine; oral
6.5
8.2
20
31
R06.0
ICD-10 Finland
Dyspnoea
1.6
8.1
220
1462
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.1
338
2490
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.2
8.1
83
395
T91.1
ICD-10 Finland
Sequelae of fracture of spine
33.6
8.1
10
*
S12.7
ICD-10 Finland
Multiple fractures of cervical spine
33.6
8.1
10
*
N99
ICPC
Neurological disease other
17.3
8.1
12
7
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
8.0
216
1435
V49
ICD-10 Finland
Car occupant injured in other and unspecified transport accidents
22.2
8.0
11
5
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
22.2
8.0
11
5
S02.61
ICD-10 Finland
Fracture of mandible, open
22.2
8.0
11
5
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.0
8.0
98
504
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
8.0
73
331
F34.1
ICD-10 Finland
Dysthymia
3.9
8.0
31
81
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
7.9
98
508
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.3
7.9
28
67
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
7.9
232
1576
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
6.6
7.9
19
29
Y86
ICD-10 Finland
Sequelae of other accidents
13.1
7.9
13
10
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.9
177
1119
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
7.8
99
516
B18.2
ICD-10 Finland
Chronic viral hepatitis C
8.5
7.8
16
19
F05.8
ICD-10 Finland
Other delirium
10.9
7.8
14
13
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
7.8
107
578
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.8
107
578
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.9
7.8
30
78
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.7
7.8
53
205
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
7.8
259
1812
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
15.1
7.7
12
8
SPAT1094
SPAT
Continuous Positive Airway Pressure
45.2
7.7
9
*
EEC35
NOMESCO Finland
Reduction and osteosynthesis of zygomaticomaxillary fracture
45.2
7.7
9
*
D07AC01
ATC
betamethasone; topical
1.5
7.7
323
2378
G04BD08
ATC
solifenacin; oral
2.3
7.6
66
293
G45.4
ICD-10 Finland
Transient global amnesia
18.5
7.6
11
6
Y09
ICD-10 Finland
Assault by unspecified means
18.5
7.6
11
6
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
7.6
66
294
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
7.6
154
946
Z72.2
ICD-10 Finland
Drug use
25.2
7.6
10
*
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
25.2
7.6
10
*
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
25.2
7.6
10
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
7.6
99
523
W06
ICD-10 Finland
Fall involving bed
10.1
7.5
14
14
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
7.5
75
356
A11
ICPC
Chest pain NOS
2.2
7.5
77
369
A99
ICPC
Disease/condition unspecnature/site
2.1
7.5
82
406
A02BC01
ATC
omeprazole; systemic
1.5
7.5
261
1845
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
7.4
75
358
R11
ICD-10 Finland
Nausea and vomiting
2.3
7.4
69
315
I61
ICD-10 Finland
Intracerebral haemorrhage
80.5
7.4
8
*
N88
ICPC
Epilepsy
80.5
7.4
8
*
V80
ICD-10 Finland
Animal-rider or occupant of animal-drawn vehicle injured in transport accident
80.5
7.4
8
*
G43.3
ICD-10 Finland
Complicated migraine
80.5
7.4
8
*
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
6.5
7.4
18
28
C10AA05
ATC
atorvastatin; oral
1.4
7.4
370
2821
XF404
NOMESCO Finland
Ambulatory ECG
2.0
7.4
96
508
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.4
618
5181
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.7
7.4
30
82
B01AC07
ATC
dipyridamole; systemic
2.9
7.3
42
146
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.8
7.3
44
160
L16
ICPC
Ankle symptom/complaint
2.0
7.3
85
430
R07.3
ICD-10 Finland
Other chest pain
2.1
7.3
81
403
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
7.3
7
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
7.3
7
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
7.3
7
*
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
7.3
7
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
+∞
7.3
7
*
I60
ICD-10 Finland
Subarachnoid haemorrhage
+∞
7.3
7
*
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
+∞
7.3
7
*
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
+∞
7.3
7
*
V87
ICD-10 Finland
Traffic accident of specified type but victim's mode of transport unknown
+∞
7.3
7
*
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
7.3
7
*
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
7.3
7
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
+∞
7.3
7
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
7.3
7
*
AA9CW
NOMESCO Finland
NA
+∞
7.3
7
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
7.3
7
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
7.3
7
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
7.3
54
221
S51.0
ICD-10 Finland
Open wound of elbow
5.2
7.3
21
41
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
15.8
7.2
11
7
V28.9
ICD-10 Finland
Motorcycle rider injured in noncollision transport accident, unspecified motorcycle rider injured in traffic accident
15.8
7.2
11
7
L29
ICPC
Musculoskeletal sympt/complt other
2.2
7.2
73
349
K04.0
ICD-10 Finland
Pulpitis
2.1
7.2
77
375
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.6
7.2
30
84
A02BC03
ATC
lansoprazole; oral
1.5
7.1
269
1931
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.6
7.1
189
1250
M03BX02
ATC
tizanidine; oral
1.4
7.1
534
4386
SPAT1153
SPAT
Removal of sutures
1.5
7.0
303
2238
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
7.0
99
542
M48.0
ICD-10 Finland
Spinal stenosis
1.9
6.9
98
533
V18.0
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident, driver injured in nontraffic accident
6.4
6.9
17
27
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
6.4
6.9
17
27
S29
ICPC
Skin symptom/complaint other
1.7
6.9
156
986
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.3
6.9
33
103
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
5.5
6.9
19
35
G43.9
ICD-10 Finland
Migraine, unspecified
5.9
6.9
18
31
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.9
228
1586
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
4.6
6.9
22
48
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.6
6.9
22
48
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.6
6.9
15
20
WX212
NOMESCO Finland
Femoral plexus blockade
4.1
6.9
25
62
G30
ICD-10 Finland
Alzheimer disease
13.9
6.9
11
8
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.8
684
5876
C01DA14
ATC
isosorbide mononitrate; oral
1.6
6.8
176
1154
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.1
6.8
34
110
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.5
6.8
49
199
SPAT1211
SPAT
Application of soft bandage
2.0
6.8
83
428
V01.9
ICD-10 Finland
Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident
11.0
6.8
12
11
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.3
6.8
19
36
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
6.8
236
1665
RS221
NOMESCO Finland
NA
5.7
6.8
18
32
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.8
283
2075
T51.0
ICD-10 Finland
Toxic effect: Ethanol
16.8
6.7
10
6
AA3AA
NOMESCO Finland
Facial bones X-ray examination
16.8
6.7
10
6
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.0
6.7
79
403
L72
ICPC
Fracture: radius/ulna
4.3
6.7
23
54
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.1
6.7
24
59
Y96.8
ICD-10 Finland
Other type of accident
7.2
6.7
15
21
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.0
6.7
35
117
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.3
6.7
31
95
NCJ62
NOMESCO Finland
Internal fixation of fracture of forearm using plate
3.7
6.7
27
74
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
6.7
40
146
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
6.7
84
439
K92.0
ICD-10 Finland
Haematemesis
3.2
6.6
32
101
D21
ICPC
Swallowing problem
6.5
6.6
16
25
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
6.6
928
8429
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.9
6.6
25
65
RF310
NOMESCO Finland
NA
12.3
6.6
11
9
S27.1
ICD-10 Finland
Traumatic haemothorax
8.7
6.6
13
15
V48.9
ICD-10 Finland
Car occupant injured in noncollision transport accident, unspecified car occupant injured in traffic accident
8.7
6.6
13
15
R5599
NOMESCO Finland
Other rehabilitation service
3.4
6.5
29
86
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.8
6.5
20
42
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.5
494
4041
G04CA02
ATC
tamsulosin; oral
1.5
6.5
270
1974
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.5
331
2520
J01MA12
ATC
levofloxacin; systemic
1.6
6.5
180
1199
S21
ICPC
Skin texture symptom/complaint
1.8
6.5
118
701
S82.4
ICD-10 Finland
Fracture of fibula alone
5.1
6.5
19
38
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
6.5
150
956
G47.9
ICD-10 Finland
Sleep disorder, unspecified
5.4
6.5
18
34
S42.3
ICD-10 Finland
Fracture of shaft of humerus
5.7
6.5
17
30
R52.9
ICD-10 Finland
Pain, unspecified
2.1
6.4
68
333
A97
ICPC
No disease
1.7
6.4
142
895
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
70.2
6.4
7
*
G30.0
ICD-10 Finland
Alzheimer disease with early onset
70.2
6.4
7
*
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
70.2
6.4
7
*
T07
ICD-10 Finland
Unspecified multiple injuries
70.2
6.4
7
*
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
70.2
6.4
7
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
70.2
6.4
7
*
ZXA10
NOMESCO Finland
Bilateral
1.6
6.4
192
1304
M19.9
ICD-10 Finland
Arthrosis, unspecified
2.8
6.4
39
144
D07AA02
ATC
hydrocortisone; topical
1.8
6.4
117
694
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
6.4
185
1248
WX320
NOMESCO Finland
Spinalanesthesy
1.5
6.4
217
1518
L12
ICPC
Hand/finger symptom/complaint
1.8
6.4
115
681
QCB00
NOMESCO Finland
Suture of skin of upper limb
4.4
6.4
21
48
V29.9
ICD-10 Finland
Motorcycle rider [any] injured in unspecified traffic accident
6.6
6.3
15
23
S12.1
ICD-10 Finland
Fracture of second cervical vertebra
8.2
6.3
13
16
S19
ICPC
Skin injury other
2.6
6.3
43
170
C07AA05
ATC
propranolol; systemic
1.7
6.3
144
915
K92.1
ICD-10 Finland
Melaena
2.3
6.3
55
247
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
6.3
123
746
Z00.0
ICD-10 Finland
General medical examination
1.6
6.3
171
1136
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.5
6.3
17
31
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.6
6.3
20
44
S01.2
ICD-10 Finland
Open wound of nose
4.6
6.3
20
44
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.9
6.3
24
63
L13
ICPC
Hip symptom/complaint
1.7
6.3
139
876
S22.2
ICD-10 Finland
Fracture of sternum
9.3
6.3
12
13
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
9.3
6.3
12
13
C03DA01
ATC
spironolactone; oral
1.7
6.3
118
710
L86
ICPC
Back syndrome with radiating pain
2.4
6.3
48
201
S02.62
ICD-10 Finland
Fracture of the condyle of the lower jaw
18.1
6.3
9
5
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
6.3
66
321
RF210
NOMESCO Finland
NA
3.4
6.3
28
84
P74
ICPC
Anxiety disorder/anxiety state
3.4
6.3
28
84
2212
FHL
Hematoma removal, subdural
+∞
6.3
6
*
G41.8
ICD-10 Finland
Other status epilepticus
+∞
6.3
6
*
S06.1
ICD-10 Finland
Traumatic cerebral oedema
+∞
6.3
6
*
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
+∞
6.3
6
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
6.3
6
*
8500B
ICD-9 Finland
Concussion, With no loss of consciousness[COMMOTIO CEREBRI,EI TAJUTTOMUUTTA]
+∞
6.3
6
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
6.3
6
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
6.3
6
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
6.3
6
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
6.3
6
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
+∞
6.3
6
*
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
6.3
6
*
RT120
NOMESCO Finland
NA
+∞
6.3
6
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
6.3
6
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
6.3
6
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
6.3
6
*
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
26.8
6.2
8
*
E960X
ICD-9 Finland
Fight, brawl, rape[TAPPELU TAI VAST VÄKIV PAHP ASEITTA,TEK/UHRIN SUHD?]
26.8
6.2
8
*
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
26.8
6.2
8
*
N04BD01
ATC
selegiline; oral
26.8
6.2
8
*
N06AX26
ATC
vortioxetine; oral
2.7
6.2
38
141
B01AB10
ATC
tinzaparin; parenteral
2.1
6.2
70
349
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.3
6.2
29
90
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.2
364
2843
J01EA01
ATC
trimethoprim; systemic
1.5
6.2
213
1498
L75
ICPC
Fracture: femur
4.5
6.2
20
45
R06AE07
ATC
cetirizine; oral
1.4
6.1
361
2820
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
4.7
6.1
19
41
WX402
NOMESCO Finland
General anaesthesia
1.6
6.1
146
938
Z73.6
ICD-10 Finland
Limitation of activities due to disability
8.6
6.1
12
14
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.4
6.1
27
81
N05BE01
ATC
buspirone; oral
3.2
6.0
29
92
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
6.0
39
148
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
651
2272
4.56
166.70
3.1
1.8
u/l
465.3
244.2
0.76
627
2092
(3020191) Ethanol [Moles/volume] in Serum or Plasma
105
46
24.64
146.34
1.9
1.2
promille
1.9
1.3
1.68
80
38
(3018677) aPTT in Platelet poor plasma by Coagulation assay
384
1211
4.02
106.25
1.9
1.9
s
30.0
30.2
0.28
371
1169
(3013826) Glucose [Moles/volume] in Serum or Plasma
949
5674
3.20
86.43
8.4
4.2
mmol/l
6.9
6.8
1.55
917
5282
(3032080) INR in Blood by Coagulation assay
756
3989
3.00
86.37
10.3
9.4
inr
1.3
1.3
0.80
223
1094
(3003458) Phosphate [Moles/volume] in Serum or Plasma
342
1184
3.52
80.16
5.9
5.0
mmol/l
1.0
1.0
1.20
318
1098
(3012095) Magnesium [Moles/volume] in Serum or Plasma
389
1461
3.32
79.98
3.7
3.0
mmol/l
0.8
0.8
1.02
366
1356
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
149
272
6.03
79.39
2.2
2.3
ug/l
768.6
388.2
0.60
139
261
(3033658) Prothrombin time (PT) actual/Normal
521
2426
2.85
72.09
5.7
3.6
%
81.7
86.3
3.64
509
2369
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
70
58
12.67
70.67
1.6
1.2
e6/l
2259.9
144.8
1.49
44
43
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
70
58
12.67
70.67
1.5
1.2
e6/l
15.9
99.0
0.41
42
42
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
756
4286
2.71
70.54
9.7
5.4
mmol/l
1.2
1.2
4.58
700
3845
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
56
31
18.79
70.15
1.9
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
554
2719
2.74
68.56
5.1
4.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
70
61
12.04
68.45
1.5
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
51
28
18.88
64.07
1.7
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
796
4778
2.59
63.76
10.1
6.2
mmol/l
1.2
1.2
3.12
666
4020
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
69
69
10.48
61.48
1.3
1.1
mg/l
656.9
504.2
0.38
62
62
(3044640) Blood type and Crossmatch panel - Blood
584
3094
2.55
60.00
2.8
2.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
66
65
10.62
59.42
4.7
5.9
umol/l
341.3
365.2
0.44
54
56
(3020779) Urea [Moles/volume] in Serum or Plasma
247
836
3.39
58.61
6.5
5.8
mmol/l
9.0
10.9
2.92
228
790
(3023183) Ammonium ion [Moles/volume] in Plasma
93
144
6.86
58.02
4.6
2.4
umol/l
35.0
40.9
0.38
80
117
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
638
3570
2.48
57.65
4.7
3.2
ng/l
41.3
77.0
1.38
516
2520
(3024561) Albumin [Mass/volume] in Serum or Plasma
703
4121
2.45
57.16
5.8
4.7
g/l
33.7
35.0
6.24
655
3804
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
741
4537
2.38
53.39
4.3
4.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
277
1087
2.94
50.54
12.5
7.1
kpa
12.6
12.3
0.40
268
1030
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
277
1087
2.94
50.54
12.5
7.1
kpa
5.1
5.1
0.03
267
1028
(3014111) Lactate [Moles/volume] in Serum or Plasma
238
874
3.09
48.74
10.1
7.0
mmol/l
1.5
1.4
1.56
230
846
(3003396) Base excess in Arterial blood by calculation
272
1084
2.88
48.06
12.7
7.2
mmol/l
1.4
0.9
0.94
222
834
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
57
62
9.55
47.71
1.4
1.1
mmol/l
4.0
3.7
1.02
51
56
(3031040) Bacteria [#/volume] in Urine by Automated count
913
6294
2.35
47.59
6.0
4.0
e6/l
768.7
3268.4
0.97
13
95
(3018418) pH of Serum or Plasma
516
2842
2.31
45.77
4.9
3.7
ph
7.4
7.4
0.08
111
501
(3026782) Osmolality of Urine
399
1984
2.43
44.58
3.3
2.6
mosm/kgh2o
537.4
564.7
1.72
356
1657
(3016018) Differential panel - Cerebral spinal fluid
38
25
15.61
43.52
1.6
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
356
1716
2.45
42.32
2.0
1.7
nmol/l
1188.2
1155.4
0.26
269
1254
(3026008) Bacteria identified in Urine by Culture
498
2778
2.25
42.12
4.0
3.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
38
29
13.45
40.09
1.5
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
239
974
2.76
39.96
2.4
1.7
%
1.8
1.4
5.06
195
851
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
438
2368
2.25
39.52
2.7
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
528
3090
2.15
38.93
4.2
3.1
e6/l
38.9
92.3
2.52
427
2360
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
592
3622
2.12
38.84
4.1
3.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
236
973
2.72
38.49
13.6
7.6
%
95.8
95.7
0.12
228
935
(36304419) Bacteria [Presence] in Urine
478
2708
2.18
38.14
4.0
2.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
750
5047
2.08
37.71
7.2
6.3
umol/l
12.5
12.5
0.01
714
4798
(3030467) Casts [#/volume] in Urine by Automated count
487
2807
2.14
36.94
4.0
3.0
e6/l
0.3
0.5
1.50
394
2092
(3000991) Gas panel - Venous blood
204
822
2.74
34.59
11.1
8.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
216
904
2.65
33.95
14.6
7.9
g/l
117.6
119.8
0.76
210
865
(3018095) Leukocytes [#/volume] in Urine
565
3539
2.02
33.44
4.9
3.5
e6/l
96.8
137.7
0.57
449
2519
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
309
1535
2.31
33.41
1.9
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1211
10062
2.77
33.22
24.6
12.9
mg/l
26.8
27.5
0.32
1105
7718
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
361
1921
2.19
32.97
4.4
3.6
ng/l
649.3
792.3
0.19
305
1616
(3000850) Epithelial cells [#/volume] in Urine
380
2068
2.16
32.76
3.4
2.5
e6/l
5.6
5.1
0.27
349
1795
(3021960) Folate [Moles/volume] in Serum or Plasma
404
2253
2.13
32.68
1.7
1.5
nmol/l
19.6
20.0
0.17
361
1880
(3014576) Chloride [Moles/volume] in Serum or Plasma
269
1273
2.39
32.44
10.0
7.0
mmol/l
104.4
104.3
0.12
264
1245
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
610
3970
1.97
31.94
2.2
1.9
pmol/l
93.8
92.5
0.27
344
2044
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
147
518
3.06
31.78
12.9
10.0
mmol/l
23.9
24.4
0.87
140
481
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
490
2979
2.00
31.02
4.2
3.1
u/l
38.7
39.2
0.03
460
2820
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
133
462
3.08
29.43
6.0
3.6
mmol/l
23.8
23.9
0.15
121
424
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
987
7731
1.99
28.10
8.9
7.2
u/l
85.0
79.9
2.02
914
7209
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
197
864
2.50
27.81
2.5
2.2
g/l
0.2
0.2
2.22
182
807
(3021447) Carbon dioxide [Partial pressure] in Venous blood
207
938
2.42
27.19
5.4
3.2
kpa
5.9
5.8
0.47
197
903
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
217
1014
2.35
26.57
5.0
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
262
1336
2.19
25.98
2.4
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
402
2401
1.95
25.92
2.3
2.1
mg/l
3.4
3.0
1.49
346
2030
(3037467) Urinalysis macro (dipstick) panel - Urine
878
6707
1.86
25.80
5.2
3.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
264
1357
2.17
25.63
30.3
28.6
inr
1.3
1.5
0.83
29
199
(3002032) Base excess in Venous blood by calculation
203
941
2.36
25.24
5.4
3.3
mmol/l
1.8
1.8
0.01
178
709
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
139
539
2.76
25.10
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
218
1051
2.28
24.71
1.9
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
177
780
2.46
24.61
4.9
2.5
kpa
4.5
4.4
0.45
165
750
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
218
1053
2.27
24.59
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
810
6086
1.81
24.57
4.7
2.7
u/l
66.9
52.4
3.20
744
5566
(3036481) Cortisol [Moles/volume] in Serum or Plasma
155
642
2.60
24.55
2.0
2.3
nmol/l
409.2
389.7
0.52
142
583
(3019060) Gas panel - Arterial blood
147
597
2.64
24.22
10.3
4.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
459
2921
1.86
24.04
3.1
2.3
u/l
57.2
59.2
0.40
434
2676
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
191
886
2.34
23.64
2.6
2.3
u/l
29.5
43.8
1.73
160
768
(3015377) Calcium [Moles/volume] in Serum or Plasma
485
3163
1.83
23.32
3.4
3.6
mmol/l
2.4
2.4
0.02
418
2734
(3012501) Base excess in Blood by calculation
67
178
3.91
22.42
4.1
4.7
mmol/l
2.6
2.7
0.05
45
118
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
134
540
2.64
22.39
15.4
9.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
208
1031
2.20
21.89
3.2
2.6
umol/l
8.9
9.9
0.35
177
901
(3019550) Sodium [Moles/volume] in Serum or Plasma
1221
10676
2.34
21.45
30.1
15.2
mmol/l
139.3
139.6
5.01
1194
10337
(3003181) Sodium [Moles/volume] in Urine
58
144
4.16
21.28
1.4
1.2
mmol/l
83.8
62.6
2.15
53
113
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
17
12.53
21.23
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1222
10702
2.33
21.15
30.1
15.4
mmol/l
4.0
4.0
3.07
1192
10341
(42870588) Differential panel, method unspecified - Blood
476
3174
1.77
20.70
6.5
5.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
287
1635
1.96
20.66
3.6
2.9
e6/l
2.5
1.8
0.63
160
918
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
9
30.56
20.60
1.6
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
54
131
4.25
20.43
1.8
1.2
—
—
—
0
0
(3010421) pH of Blood
71
210
3.51
20.33
4.2
4.4
ph
7.4
7.4
0.05
64
175
(3007853) Bacteria identified in Skin by Aerobe culture
201
1015
2.15
20.10
2.1
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
601
4315
1.70
19.80
6.8
6.0
%
0.6
0.7
0.39
559
4003
(40758558) Short blood count panel - Blood
381
2409
1.81
19.68
6.7
7.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
617
4469
1.69
19.61
6.9
6.2
%
9.0
9.0
0.15
573
4159
(3013115) Eosinophils [#/volume] in Blood
658
4848
1.69
19.61
6.9
5.9
e9/l
0.2
0.2
1.13
579
4169
(3001122) Ferritin [Mass/volume] in Serum or Plasma
532
3703
1.71
19.60
3.2
2.5
ug/l
195.1
167.0
0.57
474
3377
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
111
435
2.69
19.57
3.5
3.6
mmol/l
1.7
2.1
0.40
81
307
(3006504) Eosinophils/100 leukocytes in Blood
614
4445
1.69
19.52
6.7
5.9
%
2.9
2.9
0.03
568
4122
(3013707) Erythrocyte sedimentation rate by Westergren method
889
7113
1.71
19.25
4.3
3.7
mm/h
14.1
13.2
0.93
812
6465
(3006315) Basophils [#/volume] in Blood
639
4689
1.68
19.20
6.7
5.6
e9/l
0.0
0.0
0.45
556
3958
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
77
249
3.22
19.16
2.1
1.9
g/l
3.6
3.6
0.06
70
236
(3008152) Bicarbonate [Moles/volume] in Arterial blood
132
569
2.46
19.12
14.1
5.9
mmol/l
24.9
24.3
1.11
126
525
(3001604) Monocytes [#/volume] in Blood
636
4668
1.68
19.05
6.7
5.6
e9/l
0.6
0.6
0.33
550
3945
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
291
1708
1.89
19.00
3.3
2.7
e6/l
1.0
1.0
0.05
164
991
(3024928) Oxygen saturation in Venous blood
68
207
3.40
18.64
6.3
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
299
1782
1.87
18.57
3.4
3.3
mmol/l
2.5
2.5
0.04
257
1547
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
103
400
2.70
18.47
2.7
1.8
ug/l
3.5
2.0
0.53
80
353
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
133
585
2.41
18.42
1.7
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
113
461
2.58
18.37
3.6
3.7
kpa
5.2
5.1
0.66
106
420
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
240
1335
1.97
18.34
2.7
2.3
%
22.2
23.0
0.26
201
1153
(3036489) Thrombin time
76
251
3.15
18.26
1.6
1.6
s
21.7
22.6
0.48
70
220
(3021589) Normoblasts [#/volume] in Blood
606
4428
1.66
18.20
12.8
8.9
e9/l
0.0
0.0
0.10
499
3565
(3013650) Neutrophils [#/volume] in Blood by Automated count
729
5585
1.65
18.17
10.0
9.4
e9/l
4.3
4.2
0.31
624
4804
(3002030) Lymphocytes/100 leukocytes in Blood
622
4584
1.65
18.00
6.8
6.0
%
26.0
26.9
1.17
573
4242
(3019198) Lymphocytes [#/volume] in Blood
646
4810
1.65
17.93
6.8
5.7
e9/l
1.8
1.9
0.15
569
4169
(3009343) pH of Capillary blood
111
455
2.57
17.86
3.6
3.6
ph
7.4
7.4
0.95
18
55
(40761511) CBC panel - Blood by Automated count
1202
10643
2.07
17.24
22.8
12.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1040
8809
1.75
17.08
4.9
4.0
mu/l
1.9
2.2
0.95
916
7827
(3018010) Neutrophils/100 leukocytes in Blood
609
4507
1.63
17.04
6.7
5.8
%
57.8
57.8
0.01
563
4188
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
167
842
2.12
16.64
2.3
2.3
ug/l
8.2
7.4
0.15
142
750
(3022948) Iron [Moles/volume] in Serum or Plasma
257
1511
1.86
16.48
2.6
2.3
umol/l
12.2
12.8
0.33
238
1402
(3004789) Transferrin [Mass/volume] in Serum or Plasma
245
1422
1.88
16.34
2.6
2.2
g/l
2.3
2.3
0.04
227
1311
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
511
3662
1.63
16.01
2.4
2.1
nmol/l
74.4
78.1
2.03
449
3235
(40767503) Oxygen content in Capillary blood by calculation
58
177
3.38
15.85
2.7
2.5
%
17.0
16.1
0.75
25
87
(3028707) Methadone [Presence] in Urine by Screen method
38
86
4.52
15.72
2.6
3.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
58
182
3.28
15.18
3.8
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
78
292
2.77
15.02
3.9
3.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
998
8474
1.66
14.94
30.2
16.4
%
14.0
13.7
4.13
973
8243
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
172
919
2.00
14.58
2.8
2.6
ng/l
254.7
239.7
0.16
154
841
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
83
330
2.61
14.22
2.7
2.3
u/ml
0.3
0.3
0.31
57
175
(3017143) Hepatitis C virus Ab [Presence] in Serum
164
871
2.00
14.13
2.1
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
38
94
4.13
14.05
14.9
7.2
mmol/l
8.0
7.5
0.39
31
81
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
132
650
2.14
13.93
1.7
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
153
800
2.03
13.76
4.2
3.4
mmol/l
1.2
1.2
0.64
136
677
(3008295) Osmolality of Serum or Plasma
34
79
4.39
13.63
1.7
1.2
mosm/kgh2o
277.0
276.8
0.02
27
57
(3020630) Protein [Mass/volume] in Serum or Plasma
145
747
2.05
13.58
2.5
2.4
g/l
66.1
66.4
0.15
129
675
(3011288) Drugs identified in Urine by Screen method
48
148
3.32
12.94
4.3
2.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
843
6986
1.54
12.94
4.1
3.4
pmol/l
15.0
15.0
0.11
729
6212
(3004588) Protein electrophoresis panel - Serum or Plasma
123
610
2.12
12.73
2.5
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
52
172
3.10
12.51
3.0
2.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
69
269
2.65
12.31
2.0
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
54
186
2.98
12.13
2.0
2.1
g/l
132.6
127.5
0.44
39
126
(3035350) Ketones [Presence] in Urine by Test strip
601
4681
1.51
12.06
4.2
3.2
estimate
0.0
0.0
0.00
139
838
(3021601) Nitrite [Presence] in Urine by Test strip
602
4694
1.50
11.99
5.6
4.6
estimate
0.0
0.0
0.00
140
850
(3039000) Anion gap in Blood
57
205
2.86
11.86
18.3
5.9
mmol/l
11.4
11.1
0.18
51
177
(3018572) Chloride [Moles/volume] in Blood
57
205
2.86
11.86
18.4
5.9
mmol/l
105.6
105.7
0.06
51
177
(3047181) Lactate [Moles/volume] in Blood
71
288
2.55
11.70
16.0
5.1
mmol/l
1.4
1.3
0.20
63
249
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
16
7
23.10
11.58
1.1
1.3
mmol/l
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
16
7
23.10
11.58
1.1
1.3
mmol/l
—
—
—
0
0
(4198724)
17
24
7.16
11.43
2.5
2.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
24
7.16
11.43
1.2
1.2
umol/l
59.4
53.5
—
8
13
(3022313) Gas panel - Capillary blood
76
323
2.43
11.36
3.7
3.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
65
257
2.61
11.29
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
604
4753
1.48
11.28
4.2
3.3
estimate
0.0
0.0
0.00
135
832
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
287
1922
1.62
11.18
1.6
1.5
mg/l
1.8
1.4
0.89
217
1453
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
88
404
2.26
11.04
12.8
4.4
%
1.8
1.6
0.92
81
374
(3007930) Methemoglobin/Hemoglobin.total in Blood
87
398
2.27
11.01
13.1
4.4
%
1.0
0.9
0.94
81
368
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
64
255
2.58
10.95
4.2
4.1
mmol/l
24.7
25.0
0.19
64
231
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
64
255
2.58
10.95
2.5
1.7
g/l
37.4
37.0
0.19
53
222
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
330
2.38
10.84
2.6
1.9
g/l
6.9
7.5
2.20
57
246
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
68
281
2.49
10.80
2.9
2.0
g/l
0.9
1.5
0.57
55
244
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
295
2008
1.60
10.70
1.8
1.7
pmol/l
464.4
21153092.2
1.56
241
1631
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
303
2.42
10.53
2.7
2.0
g/l
3.2
3.2
0.01
56
244
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
330
2.35
10.39
2.6
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
191
1179
1.72
10.10
2.6
2.5
%
1.8
1.7
0.73
166
1054
(3044889) 12 lead EKG panel
855
7295
1.46
9.99
4.5
3.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
55
213
2.65
9.98
3.0
2.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
22
6.88
9.74
10.9
41.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
51
194
2.69
9.60
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
51
194
2.69
9.60
1.4
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
330
2.28
9.52
2.6
1.9
g/l
3.7
3.9
0.95
54
237
(46235355) HIV 1 and 2 tests - Meaningful Use set
195
1231
1.68
9.47
2.1
1.6
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
16
26
6.21
9.47
1.1
1.0
ng/l
23.6
36.7
1.53
11
16
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
16
26
6.21
9.47
1.1
1.0
ng/l
273.4
254.5
0.17
11
16
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
16
26
6.21
9.47
1.1
1.0
ng/l
770.0
756.4
—
8
16
(3020891) Body temperature
77
357
2.23
9.46
7.0
3.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
406
3047
1.47
9.18
3.5
2.9
ng/l
2670.7
1746.1
1.27
349
2638
(3021901) Oxygen saturation in Capillary blood
43
154
2.85
9.07
2.7
3.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
49
189
2.65
8.99
2.6
3.1
kpa
8.1
8.1
0.03
42
172
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
57
238
2.46
8.90
2.7
1.7
g/l
0.0
0.1
0.67
52
222
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
315
2.25
8.81
2.7
2.0
g/l
10.4
10.6
0.12
58
270
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1081
9760
1.51
8.70
22.6
12.9
ml/min/173m2
80.4
77.3
4.14
939
7885
(3007461) Platelets [#/volume] in Blood
1240
11566
1.77
8.70
34.7
19.2
e9/l
234.9
241.7
3.25
1204
11155
(3015235) Bicarbonate [Moles/volume] in Capillary blood
52
211
2.52
8.63
2.9
3.4
mmol/l
24.5
24.6
0.04
46
184
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
164
1015
1.70
8.55
1.9
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
1240
11576
1.76
8.54
34.5
19.1
pg
30.6
30.4
1.93
1215
11334
(3024731) MCV [Entitic volume]
1240
11577
1.76
8.52
34.6
19.1
fl
91.9
91.3
3.82
1215
11335
(3026361) Erythrocytes [#/volume] in Blood
1240
11578
1.76
8.50
34.7
19.2
e12/l
4.3
4.5
24.94
1202
11121
(3000963) Hemoglobin [Mass/volume] in Blood
1240
11583
1.75
8.42
34.9
19.3
g/l
130.9
136.2
24.77
1215
11343
(3010813) Leukocytes [#/volume] in Blood
1240
11584
1.75
8.41
34.7
19.2
e9/l
7.1
6.7
5.21
1203
11123
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
54
228
2.42
8.25
2.8
1.7
g/l
0.0
0.0
0.00
49
213
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
54
229
2.41
8.17
2.8
1.7
g/l
0.0
0.0
0.00
49
213
(40761536) Microorganisms panel - Urine sediment
134
795
1.76
8.12
4.9
3.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
651
5407
1.39
8.10
2.7
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
336
2482
1.47
8.09
4.7
3.4
estimate
0.0
0.0
0.50
134
810
(3000764) Benzodiazepines [Presence] in Urine
55
238
2.37
7.97
3.0
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
363
2733
1.45
7.88
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
50
209
2.45
7.82
1.1
1.2
titre
93.3
94.2
—
6
19
(3027008) Opiates [Presence] in Urine
55
241
2.34
7.75
3.0
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1192
11072
1.60
7.65
13.2
9.4
u/l
27.4
26.2
1.15
1147
10574
(3028300) Cannabinoids [Presence] in Urine
55
243
2.32
7.62
3.1
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1032
9352
1.42
7.09
27.6
14.5
%
38.7
39.7
2.80
691
6560
(3023520) Reticulocytes [#/volume] in Blood
141
881
1.67
7.09
2.4
2.7
e9/l
71.8
67.9
0.57
102
669
(3023419) Bacteria identified in Sputum by Culture
33
118
2.84
7.03
2.0
2.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
150
959
1.63
6.90
1.4
1.3
titre
682.8
492.1
0.43
29
212
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
75
390
1.98
6.89
1.9
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
102
587
1.80
6.87
1.9
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
103
595
1.79
6.85
2.3
2.9
g/l
11.2
10.9
0.29
94
546
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
24
5.46
6.77
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
107
632
1.75
6.61
4.2
3.5
ng/l
109.2
93.1
0.74
86
545
(3027944) Amphetamines [Presence] in Urine
52
239
2.22
6.60
3.1
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
69
354
2.00
6.59
1.7
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
157
1033
1.59
6.42
1.5
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
216
1525
1.49
6.41
1.5
1.5
g/l
2.9
2.7
0.39
124
919
(40768797) Stomach Pathology biopsy report
180
1223
1.54
6.39
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
179
1227
1.53
6.10
3.8
4.3
u/l
262.0
244.4
0.66
162
1167
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
23
5.25
6.01
1.1
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
448
3638
1.34
5.91
4.7
3.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
338
2635
1.38
5.77
2.9
2.6
umol/l
1641.4
8125.0
3.79
280
2287
(3016038) Potassium [Moles/volume] in Urine
20
60
3.37
5.73
1.2
1.1
mmol/l
30.1
35.6
0.43
14
51
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
17
5.92
5.63
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
34
140
2.46
5.56
1.8
1.3
u/ml
80.8
148.3
—
5
23
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
33
4.28
5.56
2.5
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
32
129
2.52
5.47
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
61
321
1.94
5.47
3.5
2.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
287
2198
1.39
5.43
3.8
3.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
247
2.06
5.35
1.7
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
8
11.31
5.29
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
227
1677
1.42
5.28
1.3
1.2
u/ml
1.3
2.0
0.70
61
417
(3028026) IgM [Mass/volume] in Serum or Plasma
82
483
1.74
5.16
1.9
1.9
g/l
1.4
1.5
0.05
73
427
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1076
9990
1.36
5.10
4.5
4.4
mmol/l
6.1
6.0
2.15
951
8937
(3041096) Erythrocytes [Presence] in Urine by Automated
324
2554
1.35
5.09
4.2
3.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
110
2.58
5.06
3.5
3.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
83
494
1.72
5.04
1.8
1.8
g/l
1.5
1.5
0.26
70
425
(3013512) EKG study
365
2937
1.33
4.98
4.6
3.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
36
161
2.27
4.94
3.9
3.8
e9/l
4.6
4.2
0.40
36
161
(3000093) Morphology [Interpretation] in Blood Narrative
21
72
2.95
4.88
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
102
649
1.62
4.82
2.2
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
80
479
1.71
4.77
1.7
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
31
132
2.38
4.76
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1024
9471
1.32
4.74
6.3
5.5
mmol/mol
40.9
39.7
2.96
920
8626
(3009508) Creatinine [Moles/volume] in Urine
378
3076
1.32
4.73
3.2
3.0
mmol/l
7.2
7.5
0.75
303
2544
(3025941) Bacteria identified in Stool by Culture
74
435
1.74
4.71
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
46
232
2.02
4.69
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
43
816
0.51
4.63
1.3
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
69
2.93
4.61
1.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
10
21
4.79
4.53
1.1
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
38
182
2.12
4.45
2.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
156
2.21
4.42
1.9
1.3
—
—
—
0
0
(3019225) pH of Specimen
135
935
1.49
4.40
3.9
3.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
231
1.98
4.39
1.4
1.4
ug/g
213.4
255.3
0.60
26
143
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
36
170
2.15
4.37
4.1
4.0
%
60.4
59.2
0.22
36
170
(3030981) Hyaline casts [#/volume] in Urine by Automated count
87
551
1.62
4.22
3.6
2.9
e6/l
0.3
0.2
0.52
87
538
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
249
1.92
4.20
1.9
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
121
2.34
4.19
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
258
2020
1.34
4.18
4.8
3.5
kg/l
1.0
1.0
0.20
36
288
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
154
2.17
4.14
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
91
588
1.59
4.07
2.2
1.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
13
37
3.54
4.05
1.2
1.0
u/l
132.3
101.3
—
8
28
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
13
37
3.54
4.05
1.2
1.0
u/l
85.8
28.8
—
8
29
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
47
828
0.55
3.99
1.9
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
56
320
1.78
3.97
4.0
3.6
mg/l
64.9
63.8
0.01
45
264
(3034860) Kappa light chains.free [Mass/volume] in Serum
56
321
1.78
3.93
4.1
3.6
mg/l
49.6
76.0
0.67
46
262
(1761868) Lipid panel - Serum or Plasma
285
3503
0.76
3.92
3.4
2.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
11
7.31
3.86
2.1
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
14
44
3.20
3.78
1.5
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
89
585
1.56
3.72
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
26
117
2.25
3.59
1.6
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
86
2.46
3.56
1.0
1.3
pmol/l
252.8
284.1
0.26
14
62
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
131
2.16
3.53
2.9
2.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
50
289
1.76
3.45
1.1
1.0
—
0.9
—
0
5
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
139
2.11
3.45
1.4
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
38
202
1.91
3.41
1.4
1.6
g/l
1.3
1.2
1.07
33
192
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
64
2.68
3.40
1.2
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
18
5.03
3.37
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
18
5.03
3.37
1.0
1.1
nmol/l
183.7
153.4
—
9
18
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
10
7.03
3.36
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
14
5.74
3.34
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
83
2.43
3.31
1.4
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
44
249
1.79
3.27
2.5
3.3
nmol/l
0.8
0.8
0.09
36
193
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
235
1.81
3.24
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
84
2.40
3.23
1.1
1.8
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
12
38
3.18
3.21
1.7
1.3
%
2.4
2.1
—
5
9
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
164
1.97
3.21
1.4
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
110
2.20
3.20
2.9
4.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
130
2.10
3.19
1.3
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
15
5.36
3.19
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
91
2.33
3.18
1.1
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
85
2.37
3.16
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
124
2.12
3.15
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
16
61
2.64
3.14
1.9
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
424
1.58
3.09
2.6
3.2
pmol/l
4.3
4.5
1.46
58
370
(3051651) Icteric interference index of Serum or Plasma
15
56
2.70
3.06
3.2
4.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
56
2.70
3.06
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
225
1.80
3.05
1.3
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
32
169
1.91
2.96
1.1
1.2
—
405.7
—
0
7
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
170
1.90
2.92
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
533
0.53
2.91
1.3
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
21
95
2.23
2.90
1.4
1.3
nmol/l
0.2
0.6
—
5
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
76
2.39
2.90
1.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
150
1.95
2.86
1.2
1.1
u/ml
222.1
254.5
0.41
19
94
(3020682) Albumin/Creatinine [Ratio] in Urine
368
3153
1.23
2.83
3.9
3.8
mg/mmol
10.4
7.6
0.54
228
1992
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
47
2.78
2.82
1.1
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
97
2.18
2.77
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
97
2.18
2.77
1.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
97
2.18
2.77
1.1
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
41
240
1.73
2.76
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
107
779
1.41
2.75
3.7
2.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
42
2.87
2.75
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
42
2.87
2.75
1.1
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
78
2.33
2.75
2.0
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
346
2954
1.23
2.74
3.2
3.1
mg/l
238.2
242.2
0.01
222
1867
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
10
6.02
2.70
1.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
242
1.72
2.69
1.3
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
41
242
1.72
2.69
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
20
92
2.19
2.68
1.3
1.1
u/l
121.5
62.5
0.83
15
64
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
42
250
1.70
2.68
1.9
1.9
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
86
2.23
2.64
1.8
1.5
%
65.5
66.0
—
10
53
(3017569) Oxygen content in Arterial blood
13
49
2.67
2.62
1.5
3.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
41
244
1.70
2.62
1.2
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
14
55
2.56
2.62
1.9
3.3
ph
7.4
7.4
—
6
19
(3044242) Glucose [Moles/volume] in Arterial blood
14
55
2.56
2.62
1.6
3.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
52
330
1.60
2.60
4.1
3.1
g/l
0.4
0.2
0.63
33
149
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
38
2.91
2.58
1.0
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
38
2.91
2.58
1.0
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
87
2.20
2.58
2.3
2.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
19
87
2.20
2.58
1.2
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
25
3.62
2.57
1.0
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
38
223
1.72
2.56
1.2
1.3
—
5.3
—
0
7
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
7
7.17
2.55
1.6
2.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
11
5.47
2.54
1.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
11
5.47
2.54
1.0
1.0
—
—
—
0
0
(4062490)
14
56
2.52
2.53
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
158
1.85
2.49
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
68
464
1.49
2.48
3.0
2.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
39
2.84
2.48
1.0
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
21
3.83
2.46
5.1
5.2
—
—
—
0
0
(4027681)
6
12
5.02
2.40
1.3
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
28
153
1.85
2.39
1.9
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
36
213
1.71
2.37
1.6
1.6
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
8
6.27
2.37
1.2
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
8
6.27
2.37
1.6
2.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
28
3.23
2.31
2.2
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
921
8693
1.18
2.22
32.4
17.3
g/l
332.2
332.8
1.02
909
8611
(3012441) Differential panel - Pleural fluid
23
121
1.92
2.21
1.7
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
241
1.64
2.21
1.2
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
48
2.51
2.19
1.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
48
2.51
2.19
1.8
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
136
1.85
2.18
1.5
1.4
e6/l
868.5
1996.7
1.71
17
94
(3024471) HLA-A [Type]
8
24
3.35
2.18
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
55
2.38
2.12
1.8
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
15
68
2.22
2.11
1.5
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
49
2.46
2.10
4.5
2.3
u/ml
589.1
1758.9
1.34
12
49
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
10
37
2.72
2.10
2.7
2.6
nmol/l
173.2
137.6
—
10
31
(4015189)
6
15
4.01
2.04
2.8
2.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
26
147
1.78
2.03
1.6
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
125
1.85
2.03
1.6
1.4
e6/l
26087.9
60063.6
0.57
15
75
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
162
1.74
2.03
1.3
1.3
u/l
8.9
8.2
0.19
22
133
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
26
3.09
2.01
1.0
1.2
iu/ml
177.4
188.3
—
8
26
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
187
0.42
1.93
1.4
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
27
2.97
1.93
5.5
7.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
22
3.19
1.88
1.9
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
107
833
1.31
1.86
1.9
2.0
nmol/l
13.4
13.6
0.06
96
745
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
33
206
1.62
1.84
1.9
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
62
444
1.42
1.83
1.2
1.2
u/ml
268.8
224.5
0.18
53
407
(3048689) Calprotectin [Mass/mass] in Stool
115
907
1.29
1.83
2.1
2.3
ug/g
199.4
166.9
0.33
98
720
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
73
2.07
1.81
2.0
1.3
%
25.4
21.8
—
7
41
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
35
2.58
1.80
1.1
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
231
1.57
1.80
1.4
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
29
2.77
1.79
1.0
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
61
439
1.41
1.76
3.0
3.5
u/ml
3351.2
4795.2
0.16
56
375
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
6
18
3.34
1.74
3.0
1.8
ug/l
0.3
0.3
—
6
12
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
44
298
1.49
1.74
1.7
1.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
12
54
2.23
1.74
12.5
7.8
u/ml
66.2
68.6
—
5
19
(40760892) CBC W Ordered Manual Differential panel - Blood
237
2038
1.20
1.73
5.1
4.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
153
1261
1.24
1.70
9.3
6.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
53
375
1.43
1.69
1.2
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
31
2.59
1.66
1.6
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
69
2.04
1.65
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
436
3953
1.15
1.64
2.3
2.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1015
9747
1.16
1.63
4.0
3.7
mmol/l
1.4
1.3
5.31
900
8752
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
128
1041
1.25
1.61
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
182
1.61
1.61
1.2
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
20
3.01
1.58
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
20
3.01
1.58
4.7
7.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.1
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.1
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.1
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
241
1.51
1.53
1.9
1.5
iu/ml
0.4
0.3
0.10
11
49
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
43
0.00
1.52
0.0
1.2
—
6.7
—
0
43
(3025159) Blasts/100 leukocytes in Blood
93
733
1.29
1.52
4.2
4.5
%
0.1
0.1
0.01
21
201
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
21
2.86
1.50
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
79
1.91
1.49
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
143
1190
1.23
1.48
1.4
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
109
1.75
1.47
1.6
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
109
1.75
1.47
1.3
1.6
g/l
0.7
0.9
0.56
14
84
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
132
1.68
1.46
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
28
2.51
1.45
1.3
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
80
1.88
1.45
1.5
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
29
2.42
1.39
2.1
1.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
29
2.42
1.39
2.1
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
29
2.42
1.39
1.6
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
53
2.08
1.38
3.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
53
2.08
1.38
3.0
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
23
2.62
1.37
1.8
2.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
94
755
1.26
1.35
4.2
4.4
%
0.9
0.6
0.48
22
193
(40765096) Chromosome analysis panel by Banding
0
37
0.00
1.34
0.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
39
0.00
1.34
0.0
1.9
—
9.2
—
0
34
(3017181) Myelocytes/100 leukocytes in Blood
103
838
1.25
1.33
4.0
4.4
%
1.1
0.8
0.71
30
273
(3001019) Free T4 and TSH panel - Serum or Plasma
21
332
0.63
1.33
2.0
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
287
2563
1.15
1.33
1.7
1.6
mmol/l
1.5
1.3
1.35
232
2126
(3020961) Endomysium IgA Ab [Titer] in Serum
46
334
1.39
1.32
1.2
1.1
—
201.7
—
0
6
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
13
69
1.89
1.28
2.1
2.0
ug/l
4.2
3.7
0.09
13
63
(3023511) Choriogonadotropin [Units/volume] in Urine
12
62
1.94
1.28
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
10
48
2.09
1.28
1.7
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
48
2.09
1.28
5.0
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
84
1.79
1.27
1.4
1.3
nmol/l
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
84
1.79
1.27
1.1
1.1
u/ml
2.7
3.1
—
6
35
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
253
1.43
1.25
2.6
2.4
ug/min
212.4
76.5
0.41
19
153
(40768446) Kidney Pathology biopsy report
6
25
2.41
1.24
2.7
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
123
1.64
1.24
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
20
123
1.64
1.24
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
179
1.52
1.24
5.2
5.1
iu/ml
155.3
442.8
—
6
26
(1002224) Polysomnography panel
31
212
1.47
1.23
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
49
2.05
1.22
1.7
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
19
2.64
1.21
1.0
1.0
miu/ml
2079.6
1642.5
—
5
19
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
71
1.84
1.19
1.6
1.2
nmol/l
1.0
1.3
0.71
13
63
(4024509)
12
64
1.88
1.18
1.5
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
35
248
1.42
1.17
4.0
3.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
62
482
1.30
1.17
1.3
1.2
iu/ml
89.8
162.9
0.82
16
179
(40768443) Skin Pathology biopsy report
53
404
1.32
1.15
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
158
1.53
1.15
1.4
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
95
1.69
1.14
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
31
2.26
1.10
1.7
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
96
794
1.22
1.10
4.1
4.5
%
0.0
0.1
0.63
24
247
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
355
1.34
1.10
1.1
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
180
0.55
1.07
1.1
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
74
1.76
1.07
1.8
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
97
1.66
1.07
3.1
2.2
u/field
1.7
1.7
—
9
29
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
90
1.67
1.04
1.1
1.2
u/ml
1.2
1.6
—
6
26
(3042631) Mycobacterium sp identified in Specimen
21
138
1.53
1.03
2.5
3.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
7
34
2.06
1.03
1.0
1.3
u/l
21.2
6.7
—
7
27
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
122
1.57
1.02
1.1
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
14
83
1.69
1.01
1.1
1.3
—
54.1
—
0
6
(3026250) Tacrolimus [Mass/volume] in Blood
7
35
2.01
1.00
41.1
31.7
ug/l
7.3
6.9
—
7
30
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
20
132
1.52
0.97
3.2
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
108
1.58
0.96
1.6
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
51
1.77
0.94
2.8
7.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
62
1.78
0.94
1.1
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
27
2.23
0.93
4.8
7.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
5.2
2.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
71
582
1.23
0.92
2.9
3.4
e9/l
4.2
4.1
0.14
51
440
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
63
1.75
0.90
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
104
0.48
0.89
1.2
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
71
1.70
0.89
2.8
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
42
1.91
0.88
3.5
2.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
155
0.58
0.88
1.8
1.6
—
—
—
0
0
(4146454)
15
95
1.59
0.87
3.8
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
51
405
1.27
0.87
1.6
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
21
299
0.70
0.87
1.5
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
34
256
1.34
0.85
4.6
3.1
mg/l
40.2
29.3
0.56
20
157
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
137
1.47
0.84
1.5
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
46
1.74
0.82
1.3
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
306
0.71
0.81
2.8
1.6
mg/l
2.5
3.7
0.49
17
214
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
47
1.71
0.80
1.7
3.0
u/l
197.9
199.4
—
8
47
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
499
4724
1.09
0.80
4.6
5.0
ug/l
6.7
3.8
0.32
440
4235
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
63
519
1.22
0.80
2.5
2.4
—
—
—
0
0
(3000492) Spirometry study
97
838
1.17
0.75
1.5
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
1.2
2.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
116
1.47
0.74
3.2
2.1
u/l
2852.0
2500.8
—
7
51
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
56
1.61
0.72
1.1
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
177
1.36
0.71
1.1
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
27
1.85
0.68
2.0
2.6
%
6.4
9.7
—
5
27
(21494814) CD8 cells/100 lymphocytes in Specimen
5
27
1.85
0.68
2.0
2.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
110
1.46
0.68
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
144
1294
1.13
0.66
1.3
1.2
iu/ml
37.7
40.6
0.08
38
414
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
5
28
1.79
0.66
2.4
7.8
%
51.8
73.7
—
5
23
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.6
—
30.8
—
0
6
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
80
1.50
0.60
1.0
1.0
u/ml
8.9
2.2
—
5
29
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
135
1220
1.12
0.58
1.3
1.2
u/ml
32.8
22.0
0.43
37
467
(44790048)
16
115
1.40
0.56
1.1
1.5
—
—
—
0
0
(44790047)
16
115
1.40
0.56
1.1
1.5
—
—
—
0
0
(44806118)
16
115
1.40
0.56
1.1
1.5
—
—
—
0
0
(44790049)
16
115
1.40
0.56
1.1
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
73
1.51
0.56
1.8
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
13
90
1.45
0.55
1.2
1.1
%
120.5
112.6
0.40
13
79
(40768800) Prostate Pathology biopsy report
27
340
0.79
0.55
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
265
2823
0.92
0.55
2.8
3.0
ug/l
0.7
0.8
1.58
183
1888
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(4268621)
9
62
1.45
0.53
2.6
2.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
39
1.54
0.53
1.8
2.5
e9/l
0.1
0.1
—
6
39
(4034850)
25
315
0.79
0.52
23.4
9.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
26
326
0.79
0.52
5.2
4.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1063
10456
1.07
0.52
4.9
4.6
mmol/l
2.5
2.7
11.87
952
9465
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
179
1.29
0.51
1.3
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
65
1.39
0.50
2.6
2.0
—
—
—
0
0
(4306422)
13
92
1.42
0.50
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
14
101
1.39
0.49
5.0
2.0
mg/l
18.4
23.1
—
5
23
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1039
10220
1.07
0.48
4.4
4.1
mmol/l
4.4
4.6
9.47
929
9304
(4010399)
71
625
1.14
0.48
1.4
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
46
1.52
0.48
1.3
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
244
0.78
0.47
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
117
0.68
0.46
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
117
0.68
0.46
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
117
0.68
0.46
1.4
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
117
0.68
0.46
1.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
118
0.68
0.46
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
118
0.68
0.46
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
131
1202
1.10
0.45
4.2
4.6
ug/l
5.7
28.6
2.14
102
999
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
77
1.43
0.45
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
103
1.36
0.45
3.3
2.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
103
1.36
0.45
1.0
1.0
u/ml
7.5
7.8
—
5
54
(3017704) Immunofixation for Urine
7
50
1.40
0.45
1.1
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
150
1387
1.09
0.44
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
129
1185
1.10
0.44
4.1
4.0
%
32.8
32.7
0.05
86
698
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
149
1.28
0.42
1.7
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
149
1.28
0.42
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
96
1.36
0.41
1.0
1.0
u/ml
1.5
2.3
—
5
40
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.6
2.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.0
—
8.1
—
0
7
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
51
581
0.87
0.40
3.6
3.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
314
0.82
0.40
1.5
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
61
1.31
0.39
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
80
1.38
0.38
2.4
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
26
215
1.21
0.38
1.6
1.5
e6/l
20363.2
14122.4
0.25
17
150
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
67
1.35
0.38
3.0
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
89
1.35
0.38
2.6
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
57
640
0.89
0.37
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
42
1.43
0.35
1.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
73
1.37
0.34
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
101
1.29
0.31
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
221
1.18
0.30
1.8
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
130
1.23
0.28
1.3
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1024
10126
1.04
0.28
4.4
4.1
mmol/l
1.4
1.4
6.96
909
9162
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
62
1.29
0.28
1.5
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
8
63
1.27
0.27
1.1
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
22
187
1.18
0.26
1.2
1.4
nmol/l
0.8
0.7
0.31
15
156
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
72
0.69
0.26
5.6
4.3
u/ml
19.4
35.3
—
5
72
(1617658) Protocol used for examination of sentinel lymph nodes
5
75
0.67
0.26
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
72
1.25
0.25
1.7
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.3
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
96
1.25
0.24
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
373
3833
0.96
0.24
3.8
4.3
%
21.2
22.0
0.40
179
1955
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
143
1.19
0.23
1.2
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
92
0.76
0.22
1.9
1.8
—
—
—
0
0
(44806420)
5
41
1.22
0.22
2.8
2.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
101
0.79
0.21
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.2
—
7.4
—
0
7
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
1.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
1.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
83
877
0.94
0.18
1.6
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
63
1.11
0.17
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
111
1.17
0.15
2.3
5.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
149
1.14
0.15
1.2
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
80
0.75
0.15
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
80
0.75
0.15
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
80
0.75
0.15
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
80
0.75
0.15
1.3
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
103
1.17
0.13
1.3
1.2
—
—
—
0
0
(4281824)
10
86
1.16
0.11
1.4
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
221
1.09
0.11
1.7
2.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
55
572
0.96
0.08
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
64
1.09
0.08
2.1
1.5
g/l
0.9
1.0
—
7
64
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
1.4
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
90
0.89
0.06
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
101
0.89
0.06
1.0
1.1
—
—
—
0
0
(4094501)
25
264
0.95
0.06
1.1
1.1
—
—
—
0
0
(4035726)
91
926
0.98
0.04
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
220
0.95
0.03
1.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
250
0.96
0.03
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
63
640
0.98
0.02
3.2
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
25
242
1.03
0.02
1.4
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
107
0.93
0.02
1.0
1.0
—
14.9
—
0
7
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
80
801
1.00
0.00
3.2
2.7
ml/min/173m2
66.5
61.9
0.39
35
323
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
91
911
1.00
0.00
1.5
1.3
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
3.8
4.1
nmol/l
73.5
141.1
—
6
59
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
58
0.86
0.00
2.2
3.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
79.8
—
0
5
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
30.1
—
0
5
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TRAUMAT_SUBAR_HAEMORRHAGE – Traumatic subarachnoid haemorrhage
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).